Stocktoria
NRX Pharmaceuticals, Inc. NRXP
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2017-11-20
NRX Pharmaceuticals, Inc. statistics & valuation
Market cap$156.4M
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2023 | FY2023 |
|---|---|---|---|---|---|
| Operating margin | -1122.8% | — | — | — | — |
| Net margin | -1980.8% | — | — | — | — |
| Return on assets | -220.9% | -688.2% | -412.2% | — | — |
| Return on equity | 179.6% | 108.2% | 257.0% | — | — |
| Debt / equity | — | — | -0.78× | -1.62× | -4.52× |
| Current ratio | 0.31 | 0.15 | 0.36 | 0.68 | 0.87 |
Source: SEC EDGAR filings · CIK 0001719406 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.